Loading…

Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations

A simple, specific, accurate and stability-indicating UV- Spectrophotometric method was developed for the estimation of candesartan cilexitil, using a Shimadzu, model 1700 spectrophotometer and a mobile phase composed of methanol: water in the ratio of 9:1 at wave length (λ(max)) 254 nm. Linearity w...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of pharmaceutical sciences 2011-11, Vol.73 (6), p.693-696
Main Authors: Pradhan, K K, Mishra, U S, Pattnaik, S, Panda, C K, Sahu, K C
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c491t-cb22305225c84e40000d0c0181d59603a69bb4be72c1486f51ea1ab16772fdc83
cites
container_end_page 696
container_issue 6
container_start_page 693
container_title Indian journal of pharmaceutical sciences
container_volume 73
creator Pradhan, K K
Mishra, U S
Pattnaik, S
Panda, C K
Sahu, K C
description A simple, specific, accurate and stability-indicating UV- Spectrophotometric method was developed for the estimation of candesartan cilexitil, using a Shimadzu, model 1700 spectrophotometer and a mobile phase composed of methanol: water in the ratio of 9:1 at wave length (λ(max)) 254 nm. Linearity was established for candesartan in the range of 10-90 μg/ml. The percentage recovery of was found to be in the range of 99.76-100.79%. The drug was subjected to acid, alkali and neutral hydrolysis, oxidation, dry heat, UV light and photolytic degradation. Validation experiments performed to demonstrate system suitability, specificity, precision, linearity, accuracy, interday assay, intraday assay, robustness, ruggedness, LOD, and LOQ. While estimating the commercial formulation there was no interference of excipients and other additives. Hence this method can be used for routine determination of candesartan cilexetil in bulk and their pharmaceutical dosage forms. The proposed method for stability study shows that there was appreciable degradation found in stress condition of candesartan.
doi_str_mv 10.4103/0250-474X.100254
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3480759</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A301924562</galeid><sourcerecordid>A301924562</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-cb22305225c84e40000d0c0181d59603a69bb4be72c1486f51ea1ab16772fdc83</originalsourceid><addsrcrecordid>eNptUs9vFCEYJUZj1-rdkyHx4mVWfs4wF5O62takxkNt440wwGypDExhpkn_e9nduraNcIDwvffI974HwFuMlgwj-hERjirWsF9LjMqdPQML3Laiog2jz8FiXz4Ar3K-Roi2hDYvwQGhGBOGxALMX-yt9XEcbJigCgZeKu-MmlwMMPZQwfNJdc676a5ywThdKmENLy7h-Wj1lGLWcXQafrfTVTSwjwmuiorNKk0qQBfg59n_3gofxzTMfqucX4MXvfLZvrk_D8HF8defq9Pq7MfJt9XRWaVZi6dKd4RQxAnhWjDLUFkGaYQFNrytEVV123Wssw3RmIm659gqrDpcNw3pjRb0EHza6Y5zN1ijS5NJeTkmN6h0J6Ny8nEluCu5jreSMoEa3haBD_cCKd7MNk9ycFlb71Wwcc6y2MgJb4hABfr-CfQ6zimU9mQZlRBb8_-h1spb6UIfy796IyqPKMItYbwmBbX8D6psYwenY7C9K--PCGhH0GUkOdl-3yNGchMVucmC3GRB7qJSKO8eerMn_M0G_QOvC7hx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1038803923</pqid></control><display><type>article</type><title>Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations</title><source>Open Access: PubMed Central</source><creator>Pradhan, K K ; Mishra, U S ; Pattnaik, S ; Panda, C K ; Sahu, K C</creator><creatorcontrib>Pradhan, K K ; Mishra, U S ; Pattnaik, S ; Panda, C K ; Sahu, K C</creatorcontrib><description>A simple, specific, accurate and stability-indicating UV- Spectrophotometric method was developed for the estimation of candesartan cilexitil, using a Shimadzu, model 1700 spectrophotometer and a mobile phase composed of methanol: water in the ratio of 9:1 at wave length (λ(max)) 254 nm. Linearity was established for candesartan in the range of 10-90 μg/ml. The percentage recovery of was found to be in the range of 99.76-100.79%. The drug was subjected to acid, alkali and neutral hydrolysis, oxidation, dry heat, UV light and photolytic degradation. Validation experiments performed to demonstrate system suitability, specificity, precision, linearity, accuracy, interday assay, intraday assay, robustness, ruggedness, LOD, and LOQ. While estimating the commercial formulation there was no interference of excipients and other additives. Hence this method can be used for routine determination of candesartan cilexetil in bulk and their pharmaceutical dosage forms. The proposed method for stability study shows that there was appreciable degradation found in stress condition of candesartan.</description><identifier>ISSN: 0250-474X</identifier><identifier>EISSN: 1998-3743</identifier><identifier>DOI: 10.4103/0250-474X.100254</identifier><identifier>PMID: 23112408</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Analysis ; Candesartan ; Drug stability ; Methodology ; Pharmaceuticals ; Pharmacology ; Pharmacology, Experimental ; Short Communications ; Testing</subject><ispartof>Indian journal of pharmaceutical sciences, 2011-11, Vol.73 (6), p.693-696</ispartof><rights>COPYRIGHT 2011 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Apr 2011</rights><rights>Copyright: © Indian Journal of Pharmaceutical Sciences 2011</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-cb22305225c84e40000d0c0181d59603a69bb4be72c1486f51ea1ab16772fdc83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480759/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480759/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23112408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pradhan, K K</creatorcontrib><creatorcontrib>Mishra, U S</creatorcontrib><creatorcontrib>Pattnaik, S</creatorcontrib><creatorcontrib>Panda, C K</creatorcontrib><creatorcontrib>Sahu, K C</creatorcontrib><title>Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations</title><title>Indian journal of pharmaceutical sciences</title><addtitle>Indian J Pharm Sci</addtitle><description>A simple, specific, accurate and stability-indicating UV- Spectrophotometric method was developed for the estimation of candesartan cilexitil, using a Shimadzu, model 1700 spectrophotometer and a mobile phase composed of methanol: water in the ratio of 9:1 at wave length (λ(max)) 254 nm. Linearity was established for candesartan in the range of 10-90 μg/ml. The percentage recovery of was found to be in the range of 99.76-100.79%. The drug was subjected to acid, alkali and neutral hydrolysis, oxidation, dry heat, UV light and photolytic degradation. Validation experiments performed to demonstrate system suitability, specificity, precision, linearity, accuracy, interday assay, intraday assay, robustness, ruggedness, LOD, and LOQ. While estimating the commercial formulation there was no interference of excipients and other additives. Hence this method can be used for routine determination of candesartan cilexetil in bulk and their pharmaceutical dosage forms. The proposed method for stability study shows that there was appreciable degradation found in stress condition of candesartan.</description><subject>Analysis</subject><subject>Candesartan</subject><subject>Drug stability</subject><subject>Methodology</subject><subject>Pharmaceuticals</subject><subject>Pharmacology</subject><subject>Pharmacology, Experimental</subject><subject>Short Communications</subject><subject>Testing</subject><issn>0250-474X</issn><issn>1998-3743</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNptUs9vFCEYJUZj1-rdkyHx4mVWfs4wF5O62takxkNt440wwGypDExhpkn_e9nduraNcIDwvffI974HwFuMlgwj-hERjirWsF9LjMqdPQML3Laiog2jz8FiXz4Ar3K-Roi2hDYvwQGhGBOGxALMX-yt9XEcbJigCgZeKu-MmlwMMPZQwfNJdc676a5ywThdKmENLy7h-Wj1lGLWcXQafrfTVTSwjwmuiorNKk0qQBfg59n_3gofxzTMfqucX4MXvfLZvrk_D8HF8defq9Pq7MfJt9XRWaVZi6dKd4RQxAnhWjDLUFkGaYQFNrytEVV123Wssw3RmIm659gqrDpcNw3pjRb0EHza6Y5zN1ijS5NJeTkmN6h0J6Ny8nEluCu5jreSMoEa3haBD_cCKd7MNk9ycFlb71Wwcc6y2MgJb4hABfr-CfQ6zimU9mQZlRBb8_-h1spb6UIfy796IyqPKMItYbwmBbX8D6psYwenY7C9K--PCGhH0GUkOdl-3yNGchMVucmC3GRB7qJSKO8eerMn_M0G_QOvC7hx</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Pradhan, K K</creator><creator>Mishra, U S</creator><creator>Pattnaik, S</creator><creator>Panda, C K</creator><creator>Sahu, K C</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20111101</creationdate><title>Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations</title><author>Pradhan, K K ; Mishra, U S ; Pattnaik, S ; Panda, C K ; Sahu, K C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-cb22305225c84e40000d0c0181d59603a69bb4be72c1486f51ea1ab16772fdc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Analysis</topic><topic>Candesartan</topic><topic>Drug stability</topic><topic>Methodology</topic><topic>Pharmaceuticals</topic><topic>Pharmacology</topic><topic>Pharmacology, Experimental</topic><topic>Short Communications</topic><topic>Testing</topic><toplevel>online_resources</toplevel><creatorcontrib>Pradhan, K K</creatorcontrib><creatorcontrib>Mishra, U S</creatorcontrib><creatorcontrib>Pattnaik, S</creatorcontrib><creatorcontrib>Panda, C K</creatorcontrib><creatorcontrib>Sahu, K C</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pradhan, K K</au><au>Mishra, U S</au><au>Pattnaik, S</au><au>Panda, C K</au><au>Sahu, K C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations</atitle><jtitle>Indian journal of pharmaceutical sciences</jtitle><addtitle>Indian J Pharm Sci</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>73</volume><issue>6</issue><spage>693</spage><epage>696</epage><pages>693-696</pages><issn>0250-474X</issn><eissn>1998-3743</eissn><abstract>A simple, specific, accurate and stability-indicating UV- Spectrophotometric method was developed for the estimation of candesartan cilexitil, using a Shimadzu, model 1700 spectrophotometer and a mobile phase composed of methanol: water in the ratio of 9:1 at wave length (λ(max)) 254 nm. Linearity was established for candesartan in the range of 10-90 μg/ml. The percentage recovery of was found to be in the range of 99.76-100.79%. The drug was subjected to acid, alkali and neutral hydrolysis, oxidation, dry heat, UV light and photolytic degradation. Validation experiments performed to demonstrate system suitability, specificity, precision, linearity, accuracy, interday assay, intraday assay, robustness, ruggedness, LOD, and LOQ. While estimating the commercial formulation there was no interference of excipients and other additives. Hence this method can be used for routine determination of candesartan cilexetil in bulk and their pharmaceutical dosage forms. The proposed method for stability study shows that there was appreciable degradation found in stress condition of candesartan.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>23112408</pmid><doi>10.4103/0250-474X.100254</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0250-474X
ispartof Indian journal of pharmaceutical sciences, 2011-11, Vol.73 (6), p.693-696
issn 0250-474X
1998-3743
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3480759
source Open Access: PubMed Central
subjects Analysis
Candesartan
Drug stability
Methodology
Pharmaceuticals
Pharmacology
Pharmacology, Experimental
Short Communications
Testing
title Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A36%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20Validation%20of%20a%20Stability-indicating%20UV%20Spectroscopic%20Method%20for%20Candesartan%20in%20Bulk%20and%20Formulations&rft.jtitle=Indian%20journal%20of%20pharmaceutical%20sciences&rft.au=Pradhan,%20K%20K&rft.date=2011-11-01&rft.volume=73&rft.issue=6&rft.spage=693&rft.epage=696&rft.pages=693-696&rft.issn=0250-474X&rft.eissn=1998-3743&rft_id=info:doi/10.4103/0250-474X.100254&rft_dat=%3Cgale_pubme%3EA301924562%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c491t-cb22305225c84e40000d0c0181d59603a69bb4be72c1486f51ea1ab16772fdc83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1038803923&rft_id=info:pmid/23112408&rft_galeid=A301924562&rfr_iscdi=true